Araştırma Makalesi

Evaluation of AST/Platelet Ratio Index, AST/Creatinine Ratio Index, and AST/ALT Ratio (De Ritis) in Tip 2 Diabetes Mellitus: A Tertiary Center Case–Control Study

Cilt: 23 Sayı: 2 11 Temmuz 2026
PDF İndir
TR EN

Evaluation of AST/Platelet Ratio Index, AST/Creatinine Ratio Index, and AST/ALT Ratio (De Ritis) in Tip 2 Diabetes Mellitus: A Tertiary Center Case–Control Study

Öz

Aim: The aim of this study was to compare the aspartate aminotransferase/platelet ratio index (APRI), aspartate aminotransferase/creatinine ratio index (ACRI), and AST/ALT ratio (De Ritis) between pregnant women diagnosed with tip 2 diabetes mellitus (DM) and healthy controls. Materials and Methods: This retrospective, single-center study was conducted in a tertiary referral hospital between January 2023 and January 2025. A total of 190 pregnant women were included: 95 with tip 2 DM(group 1) and 95 without(group 2). The APRI and ACRI indices, as well as the maternal and fetal outcomes, were compared between the groups. Results: In the study group, first-trimester(tr) creatinine (p<0.001) and leukocyte (WBC) counts (p=0.003), as well as third-tr AST (p<0.001) and creatinine (p<0.001), were significantly higher. In the study group, first-tr ACRI (p=0.006) and De Ritis ratio (p=0.008) were significantly lower, whereas third-tr APRI (p<0.001), ACRI (p=0.040), and De Ritis ratio (p=0.002) were significantly higher. Conclusions: In this study, first-tr ACRI and De Ritis ratios were significantly lower, while third-tr APRI, ACRI, and De Ritis ratios were significantly higher in patients with tip 2 DM compared to controls. Although first- and third-tr APRI, ACRI, and De Ritis indices differed significantly from those of the control group, they did not demonstrate predictive value for nıcu admission. These indices may reflect metabolic and hepatic changes in tip 2 DM but lack independent predictive value, though they could support multivariate models.

Anahtar Kelimeler

Destekleyen Kurum

This research received no financial support from any private or public institution.

Etik Beyan

This study was approved by the Clinical Research Ethics Committee of the University of Health Sciences, Gazi Yaşargil Training and Research Hospital (Decision No: 575, Date: 25.07.2025).

Teşekkür

The authors would like to thank the clinical staff and sonographers who supported data collection throughout the study. We also express our gratitude to the biostatistics team for their contributions to the statistical analyses. We acknowledge the assistance of the Obstetrics and Gynecology Department for providing technical and logistical support during the research process. The authors extend their appreciation to all individuals who contributed to the study but did not meet the criteria for authorship.

Kaynakça

  1. Referanslar

Ayrıntılar

Birincil Dil

İngilizce

Konular

Kadın Hastalıkları ve Doğum

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

11 Temmuz 2026

Gönderilme Tarihi

13 Aralık 2025

Kabul Tarihi

15 Ocak 2026

Yayımlandığı Sayı

Yıl 2026 Cilt: 23 Sayı: 2

Kaynak Göster

APA
Kayaalp, H., & Ayçiçek, S. (2026). Evaluation of AST/Platelet Ratio Index, AST/Creatinine Ratio Index, and AST/ALT Ratio (De Ritis) in Tip 2 Diabetes Mellitus: A Tertiary Center Case–Control Study. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, 23(2), 132-138. https://doi.org/10.38136/jgon.1841543
AMA
1.Kayaalp H, Ayçiçek S. Evaluation of AST/Platelet Ratio Index, AST/Creatinine Ratio Index, and AST/ALT Ratio (De Ritis) in Tip 2 Diabetes Mellitus: A Tertiary Center Case–Control Study. JGON. 2026;23(2):132-138. doi:10.38136/jgon.1841543
Chicago
Kayaalp, Hüseyin, ve Sertaç Ayçiçek. 2026. “Evaluation of AST/Platelet Ratio Index, AST/Creatinine Ratio Index, and AST/ALT Ratio (De Ritis) in Tip 2 Diabetes Mellitus: A Tertiary Center Case–Control Study”. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 23 (2): 132-38. https://doi.org/10.38136/jgon.1841543.
EndNote
Kayaalp H, Ayçiçek S (01 Temmuz 2026) Evaluation of AST/Platelet Ratio Index, AST/Creatinine Ratio Index, and AST/ALT Ratio (De Ritis) in Tip 2 Diabetes Mellitus: A Tertiary Center Case–Control Study. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 23 2 132–138.
IEEE
[1]H. Kayaalp ve S. Ayçiçek, “Evaluation of AST/Platelet Ratio Index, AST/Creatinine Ratio Index, and AST/ALT Ratio (De Ritis) in Tip 2 Diabetes Mellitus: A Tertiary Center Case–Control Study”, JGON, c. 23, sy 2, ss. 132–138, Tem. 2026, doi: 10.38136/jgon.1841543.
ISNAD
Kayaalp, Hüseyin - Ayçiçek, Sertaç. “Evaluation of AST/Platelet Ratio Index, AST/Creatinine Ratio Index, and AST/ALT Ratio (De Ritis) in Tip 2 Diabetes Mellitus: A Tertiary Center Case–Control Study”. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 23/2 (01 Temmuz 2026): 132-138. https://doi.org/10.38136/jgon.1841543.
JAMA
1.Kayaalp H, Ayçiçek S. Evaluation of AST/Platelet Ratio Index, AST/Creatinine Ratio Index, and AST/ALT Ratio (De Ritis) in Tip 2 Diabetes Mellitus: A Tertiary Center Case–Control Study. JGON. 2026;23:132–138.
MLA
Kayaalp, Hüseyin, ve Sertaç Ayçiçek. “Evaluation of AST/Platelet Ratio Index, AST/Creatinine Ratio Index, and AST/ALT Ratio (De Ritis) in Tip 2 Diabetes Mellitus: A Tertiary Center Case–Control Study”. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, c. 23, sy 2, Temmuz 2026, ss. 132-8, doi:10.38136/jgon.1841543.
Vancouver
1.Hüseyin Kayaalp, Sertaç Ayçiçek. Evaluation of AST/Platelet Ratio Index, AST/Creatinine Ratio Index, and AST/ALT Ratio (De Ritis) in Tip 2 Diabetes Mellitus: A Tertiary Center Case–Control Study. JGON. 01 Temmuz 2026;23(2):132-8. doi:10.38136/jgon.1841543